Kronborg O
Kirurgisk afdel A, Odense Sygehus.
Nord Med. 1993;108(10):256-8.
During the last decade, evidence from retrospective as well as prospective case-control studies suggest that screening for colorectal cancer in average-risk persons above 50 years of age may be worthwhile. Screening with proctoscopy may reduce the mortality from rectal cancer and screening with fecal occult blood tests (Hemoccult-II) may reduce the mortality from colorectal cancer. Final results from ongoing population studies will appear within a few years and there are reasons to believe that mortality for colorectal cancer may be reduced with at least 30 per cent by a combination of Hemoccult-II and flexible 60 cm sigmoidoscopy.
在过去十年中，回顾性以及前瞻性病例对照研究的证据表明，对50岁以上的平均风险人群进行结直肠癌筛查可能是值得的。直肠镜检查筛查可降低直肠癌死亡率，粪便潜血试验（Hemoccult-II）筛查可降低结直肠癌死亡率。正在进行的人群研究的最终结果将在几年内公布，并且有理由相信，通过Hemoccult-II和60厘米可弯曲乙状结肠镜检查相结合，结直肠癌死亡率可能至少降低30%。
